{"SPADE_UN_19771": {"Sequence Information": {"Peptide Name": "Tritrpticin [R2,3,12,13Dap]", "Sequence": "VXXFPWWWPFLXX", "Sequence Length": 13, "Biological Activity": ["Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P51524", "uniprotUrl": "http://www.uniprot.org/uniprot/P51524", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues.", "Pubmed ID": "29671805", "Reference": "Biomolecules. 2018;8:E19", "Author": "Arias M, Piga KB, Hyndman ME, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29671805"}, {"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "SPADE ID": "SPADE_UN_19771", "Similar Sequences": [{"SPADE_ID": "SPADE_N_03402", "Similarity": 1.0, "Sequence": "MAKFVSIITLLFAALVLFAAFDAPTMVKAQKLCERSSGTWSGVCGNNNACKNQRINLEGARHGSCNYVFP"}, {"SPADE_ID": "SPADE_N_04567", "Similarity": 1.0, "Sequence": "KARHGSCNYVFP"}, {"SPADE_ID": "SPADE_N_04587", "Similarity": 1.0, "Sequence": "EKARHGSNYVFP"}], "Hemolytic Activity": "Human PBMC:IC50=>=65 µM,Human erythrocytes:50% Hemolysis=>=65 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=4µM),Jurkat T-cell leukemia(IC50=>=65µM)"}}}